Our work is, to our knowledge, the first to systematically investigate MYO5B as a critical mediator of osteocyte-derived signals in breast cancer, thereby expanding the functional repertoire of both MYO5B and osteocytic Wnt signaling in the context of bone metastasis. This evidence concerns the gene MYO5B and breast carcinoma.